ABC aired a special from Oprah Winfrey last night about how new GLP-1 drugs are helping patients and changing the perception of obesity as a disease rather than a failure of willpower, giving even more exposure to Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Read the full article here.
Every newborn baby in England will have their DNA mapped to assess their risk of hundreds of diseases, under NHS plans for the next 10 years.
Read more here.
Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual physical therapy platform.
Read more here.